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Abstract 
 
Tip links, core components of vertebrate hearing, are thought to directly pull on 
mechanotransduction channels to transform sound into electrical signals.  Cadherin-23 (CDH23) 
and protocadherin-15 (PCDH15), the two proteins that form the tip link, belong to the cadherin 
superfamily of calcium (Ca
2+
)-dependent adhesion molecules that feature extracellular cadherin 
(EC) repeats.  These EC repeats are ~100 residues long and are similar, but not identical to each 
other in terms of fold and sequence.  CDH23 features twenty-seven EC repeats and PCDH15 
eleven, with calcium-binding sites located at the linkers between them.  With all experimental 
evidence suggesting that Ca
2+
 and highly conserved Ca
2+
-binding residues are crucial for the 
elasticity and function of the tip-link, my project focuses on a single Ca
2+
-binding site between 
EC12 and EC13 of CDH23 and its unidentified, physiological role in hearing.  This site is 
characterized by a non-canonical sequence SXD (S: serine; X: any residue; D: aspartate) where a 
serine replaces the first aspartate in what should be the canonical sequence DXD.    
Interestingly, a single missense mutation to this unique site, D1341N (SXN), results in 
non-syndromic deafness.  Alternative, but complementary experimentation was employed to 
characterize and compare wild-type (SXD) and mutant (DXD, SXN) CDH23 fragments.  Here, I 
will present the findings of size-exclusion chromatography experiments, calcium-binding assays, 
protein crystallization efforts, X-ray diffraction data collection, and a preliminary structure for 
EC1+2
D135S
.  My goal is to understand why mother nature altered a conserved Ca
2+
-binding 
residue in only one out of twenty seven instances and its direct implications on the rigidity and 
molecular strength of the tip-link.  In addition, exploring how D1318N affects vertebrate hearing 
will allow us to shape scientific study and progress in the direction of eliminating some forms of 
inherited deafness. 
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Chapter I: Introduction 
Our interaction with the world and the people we share our experiences with is enriched 
with the gift of hearing – from the inherent peacefulness of wind chimes on a sunny day to the 
deafening exclamations of O-H-I-O on Saturday afternoons and from the high-pitched squeal of 
nails on a chalkboard to the low frequency thud of a bass drum.  Hearing may have only recently 
become this specialized by selection in different species, but it is argued that the basis of the 
vertebrate auditory system arose very early in the evolution of vertebrates.  The morphology of 
the hair cell, the transducing element in all vertebrate ears, can be traced back to our most 
primitive ancestors, the agnathans and hagfish, some 430 million years ago
1,2
.  
 In its most fundamental form, our two ears must capture mechanical energy, relay it to 
the receptor organ, and transform this mechanical input to an electrical output that the brain can 
interpret.  The most valuable asset to our hearing system is housed in the inner ear where 
thousands of hair cells have the capacity to distinguish among an extraordinary frequency range 
while providing information on both the tones present and their respective amplitudes
3
.  
However, our hearing system is susceptible to three forms of hearing loss: sensorineural, 
conductive, or mixed hearing loss
4
.   
Sensorineural hearing loss comprises any disruption to the cochlea or to the nerve 
conducting the electrical impulse which could result from illness, loud noises, hereditary or 
genetic mutations.  Equally disruptive but different in form, conductive hearing loss results form 
an interference in conduction efficiency through the outer or middle ear which involves 
perforated eardrums, presence of foreign bodies in the canal, or malformations.  Conductive 
hearing loss is often corrected medically or surgically while sensorineural hearing loss is almost 
always permanent
5
.  
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With 5% of the world’s population, some 360 million people, and approximately one-
third of all people over 65 years of age suffering from a spectrum of hearing loss, one must ask 
when and how this debilitating disorder will be counteracted
6
.  With the advent of the hearing aid 
and continual advancement of the cochlear implant, progress is being made to adapt to hearing 
loss, but not to restore it to its full potential.  Unlike amphibians and birds that can induce 
supporting cells to form new hair cells or zebrafish who have some hair cell populations that are 
regenerated continually by the activity of stem cells, the 16,000 or so hair cells we are born with 
cannot be replaced via cell division
3
.  Despite extensive research, there is still much to learn 
about our complex auditory system and new therapies that could someday eliminate forms of 
deafness will result from this knowledge. 
 Structure ultimately determines function and The Sotomayor Research Group is working 
diligently to elucidate the molecular architecture of the tip link, a fine filament consisting of two 
proteins at the heart of our auditory system.  My project focuses on one of these proteins known 
as cadherin-23, an unusual calcium (Ca
2+
)-binding site within it, and its implications for the 
rigidity and molecular strength of the tip link as a whole.  To understand the importance and role 
of the tip link, I will begin by introducing the anatomical structure and molecular function of our 
hearing apparatus from the organ level down to its chemical composition.      
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1.1  The Architecture of the Outer and Middle Ear 
 The ear can be anatomically divided into three functional parts: the external, middle, and 
inner ear (Fig. 1.a).  Although the cochlea, our receptor organ, is housed in the inner ear, it 
cannot function efficiently if the necessary stimulus does not reach that location.  Each section of 
the ear provides an indispensable element to the overall goal of transforming a mechanical 
stimulus into an electrical signal that the brain can interpret.   
 
 
 
 
 
 
 
 
 
 
The outer ear is our tool for efficiently channeling this mechanical energy in the form of 
sound waves into the external auditory meatus, or ear canal.  Observing the unique shape of 
various ridges and folds of the external ear, it would be unjustified if this comical looking 
structure did not have a function.  The visible portion called the auricle not only allows for the 
channeling of mechanical energy, but it also serves the purpose of localizing sound in space by 
reflecting and absorbing certain frequency components of the sound wave
7
.  The need to localize 
sound came about by selective pressure in the evolution of mammalian hearing; it enables us to 
Figure 1.a  The Ear – Illustration by  
Max Brӧdel (1939)45 
11 
 
Figure 1.b  The wave of force from the ear drum, 
through the ossicles, and into the fluid of the inner ear. 
Adapted from 
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utilize our other senses, to direct our eyes, and to make the decision to approach or avoid another 
animal in our immediate environment
8
.  Deep to the auricle, the tympanic membrane, or ear 
drum, separates the outer ear from the middle ear. 
The middle ear is comprised of 
an air-filled pouch that has a primary 
role in sound amplification, but also a 
critical role in pressure equilibration 
between the middle ear and the 
pharynx via the Eustachian tube.  
Here, the airborne sound waves 
interact with a lever system comprised 
of three tiny bones called ossicles to efficiently transmit energy from air into liquid, the media 
inside our inner ear.  This chain of connected bones stretches from the tympanic membrane to 
the oval window in the order of the malleus, incus, and stapes.  The mechanism for amplification 
is analogous to a hydraulic car jack
9
.  The surface ratio of eardrum to oval window is 20:1 which 
allows for efficient transfer of energy to the inner ear.  Without this system functioning as an 
impedance adapter, 98% of energy would be reflected
10
. 
 
1.2  The Inner Ear and Mechanotransduction 
 The cochlea of the inner ear functions as the energy converter in this system.  At 9 mm 
across or about the size of a chickpea, this coiled structure of progressively diminishing diameter 
is wound like a snail’s shell.  From the base to the topmost portion, the cochlea consists of the 
scala tympani, the basilar membrane, the scala media, the tectorial membrane, and the scala 
12 
 
Figure 1.c  Inside the Organ of Corti  A) An illustration of the structural divisions of the inner ear 
and a zoomed out perspective of the organ of Corti that houses both inner and outer hair cells B) A 
cartoon depiction of the organization of our hair cells.  You can see one row of inner hair cells and 
three rows of outer hair cells above the basilar membrane and below the tectorial membrane.   
Both of these images are adapted from 
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B A 
vestibule respectively.  A ridge of epithelium known as the organ of Corti, extending along the 
33 mm basilar membrane, contains 16,000 hair cells and innervation from approximately 30,000 
afferent fibers carrying information on the 8
th
 cranial nerve, vestibulocochlear
3
. 
 Residing in this compartment, hair cells and their respective auditory nerve fibers are 
tonotopically organized; meaning that at any position along the basilar membrane, those hair 
cells will be more sensitive to a certain frequency.  It is known that high frequency sounds 
stimulate the base of the cochlea, whereas low frequency sounds stimulate the apex
11
.  It turns 
out that both birds and mammals evolved to form specialized inner and outer hair cells around 
the Triassic-Jurassic periods
12
.  Whereas the flask shaped inner hair cells (IHCs) form a single 
row of approximately 3,500 “transducing” cells, the cylindrical outer hair cells (OHCs) form 
three rows of approximately 12,000 “amplifier” cells7,12.  Morphologically, OHCs have the 
unique property of electromotility in which prestin, a motor protein, drives cellular length 
changes at different audio frequencies
13
.   
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On the apical end of each IHC and OHC, we find a sensory “hair” bundle (Fig. 1.d A&B) 
that serves as the actual organelle of mechanotransduction by responding to fluid movement in 
the scala media, a liquid known as endolymph that is rich in potassium
14
.  This bundle has an 
eccentrically placed kinocilium, or true cilium, that emerges during the development of the 
differentiating hair cell and many shorter actin-filled structures called stereocilia.  The direction 
of kinocilium migration predicts the orientation of the mature hair bundle and it regresses 
postnatally so it is proposed to have only a developmental role.  Universal among species, the 
stereocilia display a monotonic gradient in length along one axis and a tapering at their base 
where they meet the surface of the hair cell
15
 (Fig. 1.d C).  These properties serve our hearing 
apparatus well as a thin, filamentous fiber known as the tip link connects each stereocilia to its 
neighbor in a staircase design of increasing height (Fig. 1.d D).  
Physiologically, our sense of hearing arises from this chain of structures working in 
parallel.  First, vibrations enter the cochlea and forcefully cause the stereocilia to rock back and 
forth.  The stereocilia are arranged in a narrow cleft called the subtectorial space formed by the 
presence of the stiff tectorial membrane.  Here, the OHCs are attached to the tectorial membrane 
and the IHCs are either free standing or loosely attached
16
.  Second, displacement towards the 
tallest stereocilia causes a shearing action on the tip link which in turn pulls open an ion channel.  
Finally, the influx of potassium through this open ion channel depolarizes the cell, opens 
voltage-dependent calcium channels, and releases a neurotransmitter at the basal end of the hair 
cell creating an action potential in the dendrites of the vestibulocochlear nerve
11
 (Fig. 1.d A).  At 
the core of this process are tip links made of cadherin-23 (CDH23) and protocadherin-15 
(PCDH15), two enormous cadherins essential for hearing. 
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Figure 1.d  The elements of mechanotransduction A) A mechanical stimulus acts upon the hair cell, 
causing a tensioning of the tip link that opens a transduction channel, and creates an electrical signal that 
can be translated by the brain
46
 B) A transmission electron micrograph image from 1985 of a 
mammalian hair cell with a bundle of stereocilia on its apical end
47
 C) A high-resolution scanning-
electron microscopy image of the v-shaped structure of a bundle of stereocilia belonging to the guinea 
pig
48
 D) A high-resolution, rapid-freeze, deep-etch electron microscopy image of the tip-link, 
constructed from cadherin-23 and protocadherin-15. This structure bridges the gap between adjacent 
stereocilia
49
.    
B 
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Figure 1.e  The cadherin superfamily. 
CDH23 and PCDH15 belong to the 
Cr-2 and Cr-3 family, respectively
50
 
1.3  Introducing the Cadherin Superfamily of Cell-to-Cell Adhesion Proteins 
 
To understand the unique role of the tip 
link protein’s, CDH23 and PCDH15, I will 
briefly introduce the cadherin superfamily of cell-
to-cell adhesion molecules.  The cadherin family 
is responsible for the organization of cells into 
tissues and organs to regulate processes such as 
cell adhesion, morphogenesis, synapse formation, 
cell sorting/migration, pathological conditions 
such as cancer, and the development and function 
of more than 100 sensory cells
17
.  These proteins 
are all defined by an approximately 110 residue β-fold domain, the common structural unit 
known as the extracellular cadherin (EC) domain.  The EC domains tend to have similar amino 
acid compositions and are joined together via three calcium ions at conserved binding sites
18
.   
Even with a common structural unit, the diversity in this family is indicated by sequence 
homology and domain structure analysis, allowing for a division into subfamilies including 
classical cadherins, desmosomal cadherins, seven transmembrane cadherins, protocadherins and 
other cadherin-related molecules.  The cadherins are classified on an EC1 to EC3 basis in figure 
1.e.  Whereas the extensively studied classical cadherins contain a single-span transmembrane, 
five EC domains, and mediate adhesion by the “swapping” of opposite EC1 N-terminal β-strands 
via conserved tryptophan side chains fitting into hydrophobic pockets; other non-classical 
cadherins appear to have evolved distinct structural features and adhesive mechanisms including 
16 
 
Figure 1.f  The tip-link;  
red-box indicating solved EC 
repeats. VMD
51
 representation 
of the extended handshake. 
Adapted from 
28
 
 
EC2 
EC1 
EC2 
EC1 
CDH23 and PCDH15 that join in a novel interaction that is only recently beginning to be 
understood
17,19
.   
 
1.4  CDH23 and the Tip Link 
The tip-link, composed of CDH23 and 
PCDH15
20,21
, is the core component of hearing and 
much research has been conducted to elucidate its true 
purpose by understanding its molecular structure, 
elasticity, and deafness-related structural defects.  The 
two proteins that form the tip-link are non-classical 
cadherins with single transmembrane domains and C-
terminal cytoplasmic domains
22,23
.  Both CDH23 and 
PCDH15 also have an unusually large number of EC 
repeats, twenty-seven and eleven respectively.  These 
molecules share some fundamental similarities with 
classical cadherins, but important differences in 
structure and adhesive mechanisms make them unique.  
Tip links were first suggested to be involved in 
sensory transduction in 1984 when a group of researchers directed by Dr. Jim Pickles discovered 
an extensive array of cross-links between stereocilia, particularly the shorter stereocilium of one 
row giving rise to a single, upwards-pointing link which ran up to join the side of the adjacent, 
taller stereocilium of the next row
24
.  To visualize the structure and what we know today as the 
tip link, both scanning and transmission electron microscopy were utilized.  To provide 
17 
 
experimental evidence that this tip link was instrumental in hair-cell transduction, another group 
of researchers (Assad et. al., 1991) observed that stereocilia bundles treated with BAPTA, a Ca
2+
 
chelating saline compound, abolished transduction currents and eliminated the tip link molecule 
for a few seconds
25
.  
To identify the protein(s) that constitute the tip link, researchers (Siemens et. al., 
2004; Söllner et al., 2004) first illustrated that cadherin-23 was one possible candidate through 
studying mutations in its gene that cause deafness and age-related hearing loss.  Supporting 
evidence arose from independent immunolabeling studies in both mice and zebrafish that placed 
CDH23 to the topmost portion of the tip link structure
26,27
.  In a similar fashion, immunolabeling 
experiments identified PCDH15 in the mouse inner ear.  With supporting evidence, researchers 
(Ahmed et. al., 2006; Kazmierczak et. al., 2007) were able to make the first claims that CDH23 
forms the upper two-thirds and PCDH15 the bottom third of the tip link
20,21
.  
In 2010, Dr. Marcos Sotomayor was the first person to structurally elucidate the 
connection between CDH23 and PCDH15.  The overall fold matched the well-known Greek key 
motif of classical cadherins and three Ca
2+
 ions were in a canonical relationship at the linker 
region between repeats EC1 and EC2 of each protein, but there are several novel structural 
features that illustrate the diversity among cadherin adhesion mechanisms
28
.  Most distinctly, the 
two most amino-terminal cadherin repeats (EC repeats 1 and 2) of each protein interact to form 
an overlapped, antiparallel heterodimer that resembles an ‘extended handshake’ involving only 
four of the thirty-eight EC repeats that form the tip-link.  In this arrangement, CDH23 and 
PCDH15 form a linear array of 38, 4 nm long, cadherin domains that are ~150 nm in length and 
capable of spanning the gap between adjacent stereocilium
29
. 
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Although much knowledge has been elucidated about vertebrate mechanotransduction, 
the tip link is just one major piece to a puzzle that still holds some mystery.  To this date, the 
structure that pulls open the mechanosensitive ion channel directly termed the “gating spring” 
and the channel itself remain at large.  Specifically, many in the field debate whether or not the 
gating spring is the tip link itself or proteins other than CDH23 and PCHD15.  It may be 
provided by proteins that connect the tip link to the channel or proteins that anchor the channel to 
the underlying actin core
30
.  Mechanical measurements determined that the gating spring 
stiffness is approximately 1 mN/m
31,32
, yet steered molecular dynamics (SMD) simulations of 
EC1 and EC1+2 carried out by Dr. Sotomayor predicted the tip link stiffness to be ~40-60 mN/m  
in the presence of Ca
2+
 and at a pulling speed of 0.1 nm/ns
33
.  The different values generated for 
the gating spring stiffness, when comparing the mechanical pulling versus SMD simulations, is 
significant and a reason why scientists claimed the tip link was too rigid to serve as the gating 
spring.  There could be a more elastic element yet to be discovered that serves as the gating 
spring and it is still possible that the tip link serves the purpose.  Even though each EC repeat is 
closely related in sequence and canonical Ca
2+
-binding sites are conserved, the SMD simulations 
only accounted for EC1+2 and there could be enough variability in the other 36 repeats to render 
the tip link more compliant and conducive to 1 mN/m.   
 
1.5  Exploring an Unusual Calcium-Binding Site of CDH23 
Experiments have shown that calcium (Ca
2+
) depletion around hair cells results in 
elimination of the tip-link completely, only to reassume structure several hours after Ca
2+
 
restoration.  Molecular dynamics (MD) simulations to investigate the dynamics of the EC1+2 
portion of E-cadherin in the presence and absence of Ca
2+
 confirm that apo-cadherin exhibits a 
19 
 
much higher flexibility than the Ca
2+
-bound form
34
.  Evidence from both simulations and 
electron microscopy studies on the E-cadherin molecule show that EC1+2 demonstrates a large 
and reversible conformational transition from a rod-like structure to a more globular assembly of 
the five subdomains upon Ca
2+
 depletion
35
.  Not only are Ca
2+
 and Ca
2+
-binding residues crucial 
for elasticity and function in classical cadherins, but MD simulations also suggest that the non-
classical CDH23 EC1+2 molecules are stiff, with their molecular strength and interrepeat 
dynamics mediated by Ca
2+
 binding to highly conserved acidic residues. 
I became interested in this project after a sequence alignment comparing amino acids of 
all 27 repeats of cdh23 indicated a single non-conserved Ca
2+
 binding site between EC12-13 in 
which an aspartate is replaced by a serine (Fig. 1.g B).  The normal, conserved Ca
2+
-binding site 
is referred to as DXD (aspartate [D]-any residue [X]-aspartate [D]) whereas this aspartate to 
serine [S] variation is referred to as the SXD site.  Aspartate, an acidic amino acid, is suitable for 
coordinating a positively charged Ca
2+
 ion.  Serine, referred to as a polar amino acid, may 
coordinate a Ca
2+
 ion but to an unknown extent.  Each Ca
2+
 has multiple residues coordinating it, 
but exchanging an aspartate for a serine in one out of twenty seven conserved Ca
2+
-binding 
motifs suggests that something unusual could be transpiring at this location.  I am determined to 
understand how this variation in EC12-13 of cdh23 affects the rigidity and molecular strength of 
the tip link.   
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B 
Figure 1.g  The Ca
2+
-binding sites of CDH23 A) Sequence alignment of 
CDH23 from EC1 to EC27. Notice the conserved amino acids for the DXD 
Ca
2+
-binding site and the non-conserved substitution of a serine for an 
aspartate between EC12 and EC13
33
 B) A zoomed in view of the DXD site of 
CDH23 EC1+2, specifically with an arrow pointing to an aspartate 
coordinating the third Ca
2+
.  The goal is to understand how the wild-type 
aspartate to serine variation at the EC12+13 linker impacts the arrangement of 
this Ca
2+
-binding site and its influence over the entire structure of the tip link. 
A 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.6  Linking Mutations in CDH23 to Deafness 
As a student of American Sign Language (ASL) and one who can appreciate deaf culture 
from the outside, I can understand how some individuals suffering from a spectrum of hearing 
21 
 
loss will not refer to deafness as a disability, but as a cultural identification and linguistic 
minority.  It is not that their lack of hearing “condemns them to a world of silence”36, but that 
their lack of hearing enhances other areas of perception that allows them to live as contributing 
members of society.  Deaf culture is alive and well, but with 90% of deaf children born to 
hearing parents, those who label deafness as a disability would have a point in reasoning that this 
individual is joining a familial and societal heritage that does not consider the inability to hear an 
integral part of its day-to-day functioning.  The medical decisions that hearing parents must 
make for deaf children such as getting a cochlear implant or placing them in ASL programs at a 
young age, remains a controversial issue.  The statement, “We do not live in a deaf community. 
We live in a high-rise apartment complex” often resonates with our hearing society37.  
Deafness is the most common form of sensory impairment, it can be produced from 
various sources, and results in a wide-spectrum of expressivity.  With 500 million individuals 
predicted to be at risk for noise-induced hearing loss (NIHL), exposure to excessive noise 
through occupational exposures as musicians, farmers, construction workers, and other factors 
creates a complex disease which results from the interaction of genetics and environmental 
factors
38
.  A common form and an area of interest for my research, deafness can arise from single 
gene mutations which can cause syndromic and nonsyndromic forms of deafness, as well as 
progressive and age-related hearing loss
39
.  In fact, there are currently over 40 known missense 
mutations associated with deafness that target the EC domains of PCDH15 and CDH23
28
.  I 
previously illustrated the importance of Ca
2+
 and Ca
2+
-binding residues for the molecular 
strength and elasticity of the tip link and it seems logical that these same amino acid residues 
coordinating Ca
2+
 are often the targets of deafness mutations.  Further analysis reveals a point 
mutation at SXD in which the remaining aspartate is mutated to an asparagine. The mutation, 
22 
 
D1341N, results in inherited nonsyndromic deafness or deafness characterized by no further 
abnormalities to other parts of the body.   
After solving the structure of EC1+2 of CDH23, Dr. Sotomayor studied deafness 
mutations targeting Ca
2+
 motifs and he hypothesized based off MD simulations and Ca
2+
-binding 
assays that mutations can affect CDH23 in possibly three ways.  Pulling simulations of wild-type 
(WT) and mutant CDH23 EC1+2 with Ca
2+
 bound at sites 1-3 demonstrated comparable forces 
between the two, indicating that the mutant may be reducing CDH23’s affinity for Ca2+ and 
changing CDH23’s mechanical strength indirectly.  Thus, CDH23 would suffer from a reduced 
mechanical strength at physiological Ca
2+
 concentrations of cochlear endolymph (20-40 μM).  
Alternatively, mutations can directly modify the Ca
2+
-protein interactions to reduce the 
mechanical strength of the protein.  The last hypothesis is that mutations may be impairing the 
cis and trans interactions between both homodimer CDH23-CDH23 interactions or heterodimer 
CDH23-PCDH15 interactions of the tip link by altering interrepeat orientation and dynamics
33
.  
Even though a lot of progress has been made in identifying gene mutations that cause hearing 
loss, we still know little about the mechanisms leading to disease and I would like to see if the 
D1318N mutation causes similar structural and functional defects as the D101G mutant Dr. 
Sotomayor studied.  The overall goal is to provide an answer to this proposed question: If the tip 
link can be so susceptible to a single point mutation disrupting Ca
2+
 affinity, how is the wild-type 
SXD binding site arranged so that it maintains its functionality in comparison to DXD? 
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Chapter II: Engineering Fragments of CDH23 
Does the variation from aspartate to serine alter the overall elasticity and rigidity of the 
EC12-13 junction?  Utilizing the methodologies of X-ray crystallography, multiple Ca
2+
-binding 
assays, single-molecule force spectroscopy, and MD simulations; the scientific evidence 
clarifying this question will someday be illuminated.  However, to even be able to conduct these 
complicated experimental procedures and computational experiments, one must successfully 
transverse the central dogma with biochemical techniques to produce a sufficient quantity of 
properly-folded protein.  I will go into depth on the common experiments that I, and most other 
members of The Sotomayor Research Group, utilize for the different constructs of the tip link; 
but, I cannot explain why some constructs behave and others do not, the time that some members 
wait for crystals to grow before they can even start thinking about solving a structure, or even the 
dreaded sight of a poor size-exclusion chromatography run in which 90% of the protein is 
aggregated and unusable.  Before joining the lab I thought this was the easy part, but I have 
grown to respect the process and I find some hope in knowing that the next construct I try may 
be the one.    
 The ultimate goal of our lab is to elucidate the molecular mechanisms underlying 
vertebrate mechanotransduction and this is only possible through elucidating the tip link’s 
molecular structure in its entirety.  To understand the structure-function relationships, each 
member of the lab working on the tip link is assigned a portion of either CDH23 or PCDH15.  
From this approach, many members of the lab have had great success and discovered 
characteristics of the tip link that continue to evolve our knowledge of vertebrate hearing, such as 
domains of PCDH15 lacking Ca
2+
-binding sites entirely.  I chose to work with the non-conserved 
Ca
2+
-binding site, SXD, between EC12 and EC13.  To this end, I have engineered various DNA 
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constructs, variable numbers of EC repeats containing the area of interest, to work with ranging 
from two repeats up to five.  I detail every construct I have created since joining the lab and at 
what point in the process towards structural determination I am at.  In addition, this chapter will 
include the methodology and results for the cloning, expression, and purification of my 
constructs.   
 
2.1  Cloning Various DNA Constructs Centered Around EC12 and EC13 
 All DNA fragments in this research were generated with template cDNA of CDH23 via 
PCR from either Mus musculus or Homo sapien sources and complementary primers of each 
construct were ordered from Sigma-Aldrich.  Homo sapiens CDH23 was ordered as a synthetic 
gene from Bio Basic Inc. and Mus musculus CDH23 was obtained from U. Mueller at the 
Scripps Research Institute through Dr. David Corey at Harvard Medical School.  The fragment 
constructs were designed by using the published structure of cadherin-23 EC1 and EC2 (Protein 
Data Bank code 4APX
28
) as a reference in conjunction with sequence alignments of CDH23 EC 
repeats to avoid disrupting predicted secondary structure features
33
.  All primers included a short 
spacer sequence (5’-CCGCCG-3’) and the sequence of NdeI and XhoI enzyme restriction sites 
(5’-CATATG-3’ and 5’-CTCGAG-3’, respectively) in addition to the complementary sequence 
of the desired region of the gene to be cloned.  The DNA constructs and pET-21a(+) vector, an 
approximately 5,443 bp structure containing an ampicillin resistance gene, C-terminal histidine-
tag, and an isopropyl β-D thiogalactopyranoside (IPTG) inducible T7 promoter, were digested 
with NdeI/XhoI and ligated together.  With the recombinant DNA generated, the DNA plasmids 
were propagated by bacterial transformation via the DH5α E. coli strain.  To verify successful 
replication of the DNA of interest, each plasmid was miniprepped for isolation from the bacterial 
competent cells, analytically digested to visualize appropriate DNA fragment sizes of both the 
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insert DNA and the pET-21a(+) vector on an agarose gel, and sequenced using the T7 promoter 
and terminator primers.   
 
2.2  Protein Expression in E. coli  
 For over two decades, protein expression in the bacterium E. coli has been the most 
popular method for producing recombinant proteins.  I expressed all CDH23 constructs used in 
this study in the BL21-CodonPlus (DE3)-RIPL competent cells that enable high-level expression 
of heterologous proteins, or those expressed in a species or cell type different from where it 
originates.  In addition to containing a T7 polymerase gene that allows for high-level expression 
when induced with IPTG, the BL21-CodonPlus (DE3)-RIPL efficiency can be contributed to its 
engineered ability to contain extra copies of genes that encode the tRNAs that most frequently 
limit translation of heterologous proteins in E. coli, the rare codons.  Utilizing the NIH Rare 
Codon Calculator
40
 (RaCC) that screens for arginine (Arg), leucine (Leu), isoleucine (Ile), and 
proline (Pro), it was determined that the shortest construct I work with, a two repeat structure of 
CDH23 EC12+13, codes for seven rare codons altogether (3 Arg, 3 Pro, 1 Ile).  With this pool of 
rare tRNAs provided by the competent cells, stalled expression is overcome and over-expression 
of the protein of interest can be completed.   
 The overall goal of bacterial expression from E. coli is to obtain milligram quantities of 
the desired protein that can be utilized for different experimental techniques.  The first step 
involves transforming and plating the BL21 competent cells on an ampicillin (Amp) and 
chloramphenicol (Chlor) LB agar plate.  The Amp is specific to the pET-21a(+) vector and the 
Chlor is specific to the BL21 competent cells.  A starter culture of 20 mL Lysogeny Broth (LB) 
medium, 20 μL Amp (100 μg/mL), 20 μL Chlor (34 μg/mL), and one colony from the plate were 
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Binding (B) Buffer 
20 mM Tris-HCl pH 7.5 
10 mM CaCl2 
6 M Guanidine-HCl 
20 mM Imidazole 
 
Elution (E) Buffer 
20 mM Tris-HCl pH 7.5 
10 mM CaCl2 
6 M Guanidine-HCl 
500 mM Imidazole 
 
placed in a 37°C incubator and shaken at 225 rpm overnight for approximately 16-20 hours.  
After the required time period for sufficient bacterial growth, a 2 L large-scale culture of Terrific 
Broth (TB) medium that contained 2 mL of both Amp and Chlor was inoculated with the entire 
starter culture.  The culture grew at 37°C until it reached an OD600 between 0.4 and 0.6, at which 
point IPTG was added to a final concentration of 100 μM and the temperature was adjusted to 
30°C.  After growing overnight, the culture was removed from the incubator, pelleted, and stored 
at -20°C for at least 12 hours.          
 
2.3  Purification Under Denaturing Conditions 
 
 Recombinant proteins expressed in bacteria, CDH23 
included, tend to form inclusion bodies, or highly aggregated 
protein normally formed in the cytoplasm
41
.  To account for this 
and prevent protein degradation, purification under denaturing 
condition with Guanidine-HCl was utilized.  To prepare for 
sonication, a total of approximately 60 mL of B Buffer is added to 
detach and suspend the frozen pellet ranging from 6-8 g.  After 
sonication, the lysate was spun down in a JA-20 Beckman Hi-speed centrifuge at 20,000 rpm and 
4°C for 30 minutes to remove cellular debris.  Approximately 3 mL of Ni-sepharose high 
performance resin equilibrated with an equal volume of B Buffer was added to the protein-rich 
supernatant and nutated at 4°C for 1 hour in a batch incubation fashion.  Due to the C-terminal 
Histidine tag engineered into all of the CDH23 constructs, the desired protein chelates the Ni-
sepharose beads and remains bound until a competing molecule, imidazole, is used to elute it.     
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30 
30 
40 
 All supernatant is collected via centrifugation at 3,000 rpm/4°C, and loaded onto an SDS-
PAGE gel for analysis (the following steps are detailed visually in figure 2.a).  After nutation, 
the suspension of Ni-sepharose resin and B Buffer is spun down and the supernatant, denoted as 
the flow-through (FT), containing the majority of undesired cellular proteins is removed.  With 
the CDH23 construct still bound to the Ni-sepharose resin, the mixture is washed with 30 mL 
additions of Buffer B followed by centrifugation and collection twice, in two successive rounds 
(denoted W1 and W2).  To elute the desired CDH23 protein from the Ni-sepharose resin, 30 mL 
of E buffer containing a much higher concentration of imidazole is added, the suspension 
centrifuged, and the supernatant of denatured protein collected.     
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Figure 2.a  Purification under denaturing 
conditions A) Sequence of events 
including protein expression, sonication, 
and purification via batch incubation B) 
SDS-PAGE purification gel of Mm 
CDH23 EC12-14.  Notice the amount of 
protein lost in the FT.  This is due to poor 
chelation between the Ni-sepharose resin 
to the His-tag on the protein or conducting 
the experiment with an insufficient amount 
of Ni-sepharose resin  
L FT W1 W2 E 
A 
B 
28 
 
Dialysis Buffer 
20 mM Tris-HCl pH 8.0 
2 mM CaCl2 
150 mM NaCl 
400 mM Arginine 
 
SEC Buffer 
20 mM Tris-HCl pH 8.0 
2 mM CaCl2 
150 mM NaCl 
2.4  Refolding and Separation via Size-Exclusion Chromatography 
 The 30 mL elution of protein solution, confirmed to be 
0.5<[CDH23]<1.0 mg/mL, was diluted further by separating into 
two conical vials; each with 15 mL protein solution, 15 mL E 
buffer, and 150 μL of DTT.  The contents of each tube was 
pipetted into its own dialysis membrane and placed into the 
dialysis buffer at 4°C.  The membranes were left in the buffer 
overnight to gradually remove the Guanidine-HCl until the desired protein construct refolded.  
The dialyzed solution was centrifuged at 20,000 rpm for 15 minutes at 4°C as a precautionary 
step to remove any precipitated protein.  At this point, the clear solution of diluted protein is 
either well-folded or aggregated and the sample must be prepared for size-exclusion 
chromatography (SEC).  A 10,000 MWCO polyethersulfone (PES) concentrator (Sartorius 
VIVASPIN 20) is utilized to concentrate the supernatant to either 2 mL or 5 mL, depending on 
the protein concentration and availability of a 5 mL SEC loop.  Prior to running the protein on 
the SEC, the protein concentration ranged from 5-15 mg/mL. 
 SEC with the S200 Superdex 16/60 GL (GE Healthcare) was used to separate all protein 
constructs presented.  This purification method allows for a separation of molecules according to 
differences in size and its high resolution fractionation makes it a suitable step to polish off our 
purification scheme.  By using an SEC media that consists of a porous matrix of inert spherical 
particles (Fig. 2.b A&B), large molecules such as aggregated protein elute first while smaller 
molecules, the well-folded CDH23 constructs, with low hydrofluidic volumes enter the pores and 
elute last allowing for efficient separation into a 96-well block.  The SEC column is equilibrated 
with SEC buffer, the concentrated protein solution is filtered using a 0.22 μm PES membrane 
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(Sartorius Minisart
®
), and it is then loaded onto a 5-mL loop for separation.  The spectrum 
consists of an x-axis of mL of solution eluted and a y-axis of absorbance, measuring the protein 
abundance via UV absorbance at 280 nm (Fig. 2.b D).  By identifying the separate peaks on the 
spectrum, one can select appropriate fractions to be analyzed on a Coomassie-stained SDS-
PAGE gel to access the purity of the CDH23 fragment of interest.     
 
        
 
 
  
 
 
 
   
 
 
 
 
 
 
 
 
 
Figure 2.b  Size-exclusion 
chromatography A)  SEC 
bead with an electron 
microscopic enlargement 
B)  Cartoon illustration of 
molecules diffusing into 
bead pores C)  Stages of 
separation (i) sample 
applied to column at t=0 
(ii) smallest molecule 
(yellow) is more delayed 
than largest molecule (red) 
(iii) largest molecule will 
elute first from the column. 
*Notice relationship 
between C) and D) with 
band broadening 
corresponding to peak 
width D)  Illustration of 
SEC spectrum. Vo is void 
volume (~30% of total 
column volume) and Vt is 
one total column volume.  
Adapted from 
52
     
A B C 
D 
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2.5  Results: Cloning, Purification, and Separation of Wild-Type CDH23 Constructs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.c  Wild-type constructs of CDH23 A)  Focused on a Ca
2+
-binding site 
between EC12+13, both human (Hs) and mouse (Mm) constructs were ligated into 
the pET-21a(+) vector and expressed to study the location of interest.  Hs CDH23 
EC11-13 failed to refold, Mm CDH23 EC11-13 and EC11-14 are in progress, and 
the results for Mm CDH23 EC12+13, EC12-14, EC12-15, and EC12-16 are 
below. B)  Information on the constructs illustrated above   
A
B 
Construct Residues # of Residues Molecular Weight (Da)
Hs EC 11-13 N1075 to N1391 317 35,164.20
Mm EC 11-13 N1075 to N1389 315 34,808.90
Mm EC 11-14 N1075 to N1500 426 46,743.10
Mm EC 12+13 E1181 to N1389 209 22,788.50
Mm EC 12-14 E1181 to N1500 320 34,722.70
Mm EC 12-15 E1181 to N1605 425 46,294.50
Mm EC 12-16 E1181 to N1717 537 58,497.00
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Figure 2.e  SEC data for Mm CDH23 EC12+13, EC12-14, EC12-15, and EC12-16 with SDS-
PAGE gels for validation.  All constructs were refolded with the same dialysis buffer [20 mM 
Tris-HCl pH 8.0, 2 mM CaCl2, 150 mM NaCl, 400 mM Arginine] overnight and run through the 
column with the same SEC buffer [20 mM Tris-HCl pH 8.0, 2 mM CaCl2, 150 mM NaCl]  
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2.6  Conclusions 
 Obtaining purified, well-folded protein is an obstacle for many that often requires 
significant time and problem solving strategies to overcome.  I experienced my fair share of 
frustration as I spent a good portion of one semester and a month of summer unsuccessfully 
trying to force the Hs CDH23 EC11-13 and Mm CDH23 EC12-14 constructs to refold.  After 
giving up on the Hs construct, a bit of luck, and an elongated N-terminal addition to the protein; 
it became evident that Mm CDH23 EC12-14 refolds with a standard dialysis buffer that had 
previously been successful for other group members working with cadherins.  Since this 
discovery approximately four semesters ago, I have had varying levels of success refolding and 
separating all Mm CDH23 constructs ranging from two (EC12+13) to five (EC12-16) EC 
repeats.  Capable of producing sufficient quantities of protein for a multitude of constructs, I 
have been able to set many crystal trays with different constructs in pursuit of deciphering a 
molecular structure of CDH23 around my location of interest. 
 Before I present my protein crystallization and X-ray crystallography data, I want to hone 
in on the importance of site-directed mutagenesis and how I was able to generate additional 
mutant constructs (both engineered and diseased) to perform assays that test for Ca
2+
-binding 
affinity.  I will begin in a similar fashion to this chapter by introducing the methodology as well 
as categorizing the mutant constructs and showing SEC data.  Next, I will present data from a 
trypsin sensitive assay and differential scanning fluorimetry (DSF) to evaluate protein stability 
via fluorescence. 
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Chapter III:  Designing Engineered and Diseased CDH23 Mutants for Analysis 
It is easy to be consumed by both the excitement and disappointment that is X-ray 
crystallography; a technique that relies on testing any and all combinations of buffer components 
to find the one that grows well-diffracting protein crystals.  This focus on one area of research 
distracted me from other methods that could potentially provide the same information I was 
seeking, just in a different form.  Instead of visualizing the SXD Ca
2+
-binding site through 
structural determination, perhaps I could perform an assay to measure Ca
2+
-binding and 
quantitatively analyze how this non-conserved site influences protein stability.  With this idea, I 
turned to site-directed mutagenesis to create both engineered and diseased CDH23 constructs. 
There are many reasons to create specific DNA alterations and one of them is to perturb a 
gene and analyze its subsequent activity.  For CDH23, site-directed mutagenesis provides an 
opportunity to alter the WT EC12+13
S1316
 (SXD) construct into an engineered, EC12+13
S1316D
 
(DXD), and a deafness, EC12+13
D1318N
 (SXN), mutant.  Creating mutations into the EC12+13 
SXD site is insightful, but the sequence homology between all twenty-seven EC repeats of 
CDH23 also provides an opportunity to build the SXD site of interest into a construct that has 
previously been structurally elucidated such as EC1+2.  The advantage lies in the fact that we 
know how to crystallize this construct and the disadvantage arises from the significant difference 
in amino acid composition between EC1+2 and EC12+13 (~28% sequence identity), despite our 
knowledge that all EC repeats are generally conserved in terms of structure. 
Regarding the non-conserved SXD binding site in only one-out-of-twenty seven EC 
repeats, I hope to illuminate how the aspartate to serine variation maintains the tip-links 
functionality and at what cost.  Could it impact the rigidity of the tip-link enough to introduce a 
kink into what is proposed to be a linear structure?  Regarding the SXN binding site, I want to 
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know how one single amino acid alteration can have as drastic of a result as deafness.  Is the 
non-conserved SXD binding site already weak enough compared to the conserved DXD binding 
site that losing one more Ca
2+
-binding residue is too much to handle?  With these constructs, I 
can combine X-ray crystallography and Ca
2+
-binding assays to holistically analyze the three and 
answer the proposed questions that I have.  
           
3.1  Site-Directed Mutagenesis of CDH23 EC1+2, EC12+13 and EC12-14 
 Variant constructs were generated with 
the QuikChange Lightning Site-Directed 
Mutagenesis Kit from Agilent.  The procedure 
utilizes a supercoiled double-stranded DNA 
vector, an insert of interest, and two mutant 
primers created via the Agilent primer design 
tool.  Each primer is complementary to one 
strand and encodes the missense mutation of 
interest that will generate a plasmid containing 
one different codon compared to the parental 
strand after the temperature cycling of PCR is completed.  Bacteria perform DNA methylation so 
the amplified product is treated with the Dpn I endonuclease that is specific for methylated and 
hemimethylated DNA which will digest the parental strand and not affect the mutation-
containing synthesized DNA.  The newly synthesized DNA is used to transform XL10-Gold 
competent cells which are lysed via sonication, the new vector was purified using the QIAGEN 
Figure 3.a  Site-Directed Mutagenesis 
to create CDH23 EC12-14
S1316D
 
confirmed via sequencing   
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Miniprep kit, and the desired DNA sequenced.  Please refer to Chapter 2 for details on the 
expression and purification of CDH23 mutant constructs.  
 
3.2  Trypsin Sensitivity Assay 
Refolded protein of CDH23 EC1+2, EC12+13, and EC12+13
S1316D
 in SEC buffer [20 
mM Tris-HCl pH 8.0, 2 mM CaCl2, 150 mM NaCl] were diluted to approximately 3 mg/mL.  
Calcium is everywhere and the success of this experiment is contingent on decalcifying the 
protein to be used, F-buffer [10 mM MOPS pH 7.5, 100 mM KCl], trypsin, and any materials the 
assay reagents will be in contact with.  For this reason, Chelex resin (Chelex 100) is used to 
remove all Ca
2+
 from solution so that the final concentration of Ca
2+
 is from the desired amount 
added.     
 
  
 F-buffer is separated into two 50 mL conical vials, 2% chelex resin (2 g/100 mL) is 
added, and the solution is nutated for two days.  The protein solution and trypsin, 3 mg dissolved 
in F-buffer with 2 mM HCl, is chelated the day the experiment is to be conducted.  To ensure 
that the free Ca
2+
 concentration is less than 20 nM, the chelated protein and F-buffer is calibrated 
against different calcium standards with Fura-2 (25 ng/µL) by measuring the absorbance maxima 
from ~348 nm to ~355 nm. 
 With the protein at the desired concentration and all substances decalcified, the 
experiment can be conducted by adding all reagents (Fig. 3.b) to a 96-well plate.  A gradient of 
Ca
2+
 concentrations are utilized to visualize at which point the protein is not sufficiently 
protected from trypsin degradation.  Notice that 0.5 M EGTA, a metal ion chelating agent with a 
high affinity for Ca
2+
, is added at 0 µM Ca
2+
 so the protein should be fully degraded.  Also, a 
1600 µM Ca
2+
 sample at the end of the Ca
2+
 gradient acts as another control and the protein 
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[Ca
2+
] (µM) 0 16 32 64 128 256 320 480 800 1600 1600
protein 46 46 46 46 46 46 46 46 46 46 46
F-buffer 0 0 0 0 0 0 0 0 0 0 2
CaCl2 0 2 2 2 2 2 2 2 2 2 2
0.5 M EGTA 2 0 0 0 0 0 0 0 0 0 0
Trypsin 2 2 2 2 2 2 2 2 2 2 0
Total (µL) 50 50 50 50 50 50 50 50 50 50 50
should not be digested because no trypsin is added.  Between these two extremes, a shift from 
degraded to intact protein should be visible on the SDS-PAGE gel.     
 
The reaction time can range from 30 min to 90 min and can be conducted at room 
temperature or 37°C.  After the allotted time, the reaction is quenched with 2 µL of PMSF, a 
trypsin inhibitor, and the separate wells are boiled after addition of 17 µL of SDS loading dye.  
Multiple SDS gels (4% stacking/20% resolving) were casted and the eleven reactions covering 
the spectrum of Ca
2+
 concentration were run for analysis. 
 
3.3  Differential Scanning Fluorimetry 
 Whereas the trypsin sensitive assay provides comparative data on Ca
2+
-binding affinity, 
Differential Scanning Fluorimetry (DSF) determines the structural stabilities of protein variants 
with the melting temperature (Tm), the midpoint of the protein unfolding transition
42
.  Stable 
proteins have a higher Tm than unstable proteins and are less susceptible to unfolding and 
denaturation than their counterparts.  This method is high-throughput, uses a very small amount 
of sample, and it is relatively inexpensive; it utilizes a real-time PCR machine to heat up a 96-
well plate that can contain up to 96 different samples.  DSF is based on monitoring the binding 
of a discriminating hydrophobic dye, SYPRO® Orange, to the protein of interest over a 
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Figure 3.b  Calculating the Tm of the protein by measuring fluorescent signal 
over a thermal range.  Sypro® Orange dye binds non-specifically to exposed 
hydrophobic regions as the well-folded protein unfolds and aggregates.  Figure 
courtesy of members from the Sotomayor Lab  
temperature range due to the protein unfolding into a molten globule or thermal denaturation 
intermediate (Fig. 3.b). 
  
 
 
 
 
 
 
 
 
 
 
 
 
After completion of site-directed mutagenesis and the techniques outlined in Chapter 2 
concluding with SEC, the well-folded protein is diluted to a concentration of 0.3 mg/mL.  Next, 
SYPRO® Orange is added to the protein solution and dispensed into a 96-well plate in triplicate.  
The tray is placed into a real-time PCR machine and heated from 10°C to 95°C for 425 cycles, 
the temperature increasing by 0.2°C per cycle.  During this interval, the fluorescent changes are 
measured for wavelength of emission at 575 nm.  The hydrophobic dye binds non-specifically 
and the fluorescence signal of the sample sharply increases as the protein unfolds, exposing 
hydrophobic regions to the polar environment. 
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B 
Mm CDH23 EC1+2 D135S        
Mm CDH23 EC12+13 S1316D        
Mm CDH23 EC12+13 D1318N       
Mm CDH23 EC12-14 S1316D       
 Yes 
 No
 In progress
o Not attempted
3.4  Results: Cloning, Purification, and Separation of Mutant CDH23 Constructs 
 
  
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.c  Mutant constructs of CDH23 
A) The progress of each mutant CDH23 
construct to date B) Miniprepped WT 
DNA in the pET-21a(+) vector was altered 
with the Quikchange Lightning Site-
Directed Mutagenesis Kit and the resulting 
mutant DNA was purified and isolated for 
use.  This method was used to produce 
engineered (EC1+2
D135S
, EC12+13
S1316D
, 
EC12-14
S1316D
) and deafness 
(EC12+13
D1318N
) constructs C) Information 
on the constructs illustrated above   
A 
C 
Construct Residues # of Residues Molecular Weight (Da)
Mm EC 1+2D38S Q1 to D205 205 22,584.10
Mm EC 12+13S1316D E1181 to N1389 209 22,816.50
Mm EC 12+13
D1318N E1181 to N1389 209 22,787.50
Mm EC 12-14S1316D E1181 to N1500 320 34,750.70
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Figure 3.d  SEC data for Mm CDH23 EC1+2
D135S
, EC12+13
D1318N
, EC12+13
S1316D
, and 
EC12-14
S1316D
 with SDS PAGE gels for validation.  All constructs were refolded with the 
same dialysis buffer [20 mM Tris-HCl pH 8.0, 2 mM CaCl2, 150 mM NaCl, 400 mM 
Arginine] overnight and run through the column with the same SEC buffer [20 mM Tris-HCl 
pH 8.0, 2 mM CaCl2, 150 mM NaCl]  
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Figure 3.e  Trypsin assay of CDH23 
EC1+2 and EC1+2
D101G
 from 
33
 that 
served as the inspiration and protocol 
for my own.  The WT protein requires 
much less Ca
2+
 to protect it from 
trypsin digestion, indicating a greater 
Ca
2+
-binding affinity.     
3.5  Results: Trypsin Sensitivity Assay Analysis 
Trypsin cleaves cadherins and all proteins 
at the carboxyl side of the amino acids lysine and 
arginine unless inhibited by divalent cations such 
as Ca
2+
.  The protein variant that has a higher 
affinity for Ca
2+
 will require a lower 
concentration of additional Ca
2+
 to protect it from 
the trypsin and vice versa.  Past trypsin sensitive 
assay experiments have tested the Ca
2+
-binding 
affinity between wild-type CDH23 EC1+2 and a 
known deafness mutation that was believed to 
cause a decrease in cadherin stability by reducing 
its affinity for Ca
2+
 (Fig 3.g).  I will use a similar 
approach.   
There are several outcomes possible in these experiments, but I want to focus on two.  
Result 1, both the wild-type and mutated version produce similar binding affinities postulating an 
insignificance in residue coordination at the SXD site.  Result 2, the mutated version outperforms 
the wild-type thereby suggesting that variation from aspartate to serine does indeed have some 
implications in physiological context.     
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EC1+2 
EC12+13 
EC12+13
S1316D 
EC1+2 
EC12+13 
EC12+13
S1316D 
37°C 
RT 
Figure 3.f  The results of a 
trypsin assay (t=30 min)  
A) The proteins of interest 
(Mm CDH23 EC1+2, Mm 
CDH23 EC12+13, and Mm 
CDH23 EC12+13
S1316D
) are 
analyzed on an SDS-PAGE 
gel.  The top and bottom 
experiments were conducted 
at 37 °C and room 
temperature (RT), 
respectively.  Notice how 
both of the EC1+2 intact 
protein bands at ~25 kDa 
increase in proportion along 
the Ca
2+
 concentration 
gradient from 0-1600 µM.  
This allows for quantitative 
measurements by measuring 
the intensity of the band with 
ImageJ B) Graphing the 
normalized intensities for 
EC1+2 against the Ca
2+
 
concentration gradient and 
fitting the spectrum to obtain 
the effective Kd  
y = % (normalized band intensity) 
x = [Ca
2+
] 
Kd = Dissociation constant 
n = Hill coefficient 
A 
B 
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 Mm CDH23 EC1+2 was the only protein gel that was able to be quantitatively analyzed 
with ImageJ and fitted to the equation presented in Fig. 3.g.  This construct was added to the 
trypsin binding assay to serve as a control, as previous experimentation determined the Kd to be 
86.8 µM
33
.  The Kd’s do not match exactly, but they do allow me to believe that the results for 
EC12+13 and EC12+13
S1316D
 are indicative of the truth.     
Construct Kd (µM) R
2 
n (Hill coefficient) 
EC1+2 (37) 62.38 0.9700 2.235 
EC1+2 (RT) 33.58 0.9571 1.165 
 
 The ambiguity presented in band intensity for Mm CDH23 EC12+13 and EC12+13
S1316D
 
did not allow for quantitative analysis, but it can be qualitatively analyzed to an extent.  Viewing 
the SDS-PAGE gels for 37°C, it seems that these two constructs require a higher Ca
2+
 
concentration to protect them from trypsin degradation when compared to EC1+2, as band 
intensity significantly increases towards the 480 µM concentration.  Further data is needed to 
confirm this difference in Kd, and even more specifically, conclude whether or not this difference 
has any implications for the physiology of the tip link. 
 Comparing EC1+2 against EC12+13/EC12+13
S1316D
 seems to be more justified than 
comparing the two constructs of EC12+13.  At first glance, it does seem that EC12+13 does 
require less Ca
2+
 to protect it from trypsin digestion, therefore indicating that it binds Ca
2+
 to a 
greater extent than the engineered mutant, EC12+13
S1316D
.  Initially planning this experiment, I 
predicted that this mutant would have an increased binding capacity for Ca
2+
 because technically 
it is engineered to do so, with the swapping of the WT serine for the conserved aspartate.  
However, more experimentation is needed to make any conclusions and DSF will also give us an 
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Figure 3.g  The normalized and 
averaged DSF spectrum for 
CDH23 variants performed in 
triplicate and the experimentally 
determined melting temperatures.  
idea of the binding capacities in the next section.  It was my intention to compare Mm CDH23 
EC12+13, EC12+13
S1316D
, and EC12+13
D1318N
, but the many trials I conducted produced SDS-
PAGE gels that were too ambiguous for analysis.    
 
3.6  Results: Differential Scanning Fluorimetry 
 All data presented for DSF was conducted in triplicate with CDH23 EC12+13, 
EC12+13
S1316D
, and EC12+13
D1318N
.  With three independent measurements for one protein, the 
fluorescence signal was normalized per run to the maximum intensity over the entire range of 
data (425 readings) from 10°C to 94.8°C to produce a ratio between 0 and 1. 
0 − 1.0 =
𝑆𝑖𝑔𝑛𝑎𝑙 − 𝑀𝐼𝑁(1: 425)
𝑀𝐴𝑋(1: 425) − 𝑀𝐼𝑁(1: 425)
 
Next, the three calculations for each temperature point were averaged and then graphed, where 
the Tm is given by the point at which the fluorescence signal equals 0.5. 
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The data indicates that the melting temperatures for CDH23 EC12+13
S1316D
 and EC12+13
D1318N
 
are lower than the WT protein, indicating that the mutations have some effect on the stability of 
the protein’s secondary structure.  Additional experiments with DSF will be conducted in the 
near future to confirm these results.   
 
3.7  Conclusions 
 It was my hope that this chapter’s experimental techniques would show that the non-
conserved SXD site afflicted the WT EC12+13 portion of the tip link with a decreased Ca
2+
-
binding affinity and overall decline in stability when compared against the engineered mutant, 
EC12+13
S1316D
.  Unfortunately, this was not the consensus.  One preliminary conclusion from 
the trypsin assay is that Mm CDH23 EC1+2 maintains a greater Ca
2+
-binding affinity than both 
Mm CDH23 EC12+13 and EC12+13
S1316D
.  The other preliminary conclusion from DSF is that 
the Mm CDH23 EC12+13 construct is more stable than the engineered, EC12+13
S1316D
, and 
diseased, EC12+13
D1318N
, mutant constructs.  If the degree of Ca
2+
-binding is directly correlated 
with protein stability, then this could indicate that EC12+13 (SXD) does have a higher Ca
2+
-
binding affinity than EC12+13
S1316D
 (DXD) despite the trypsin assay uncertainty.  Yet, 
EC12+13
D1318N
 which is proven to cause deafness creates some distrust in measurements by 
showing a greater stability than the EC12+13
S1316D
 mutant, despite being close in value. 
 Contrary to my hypothesis that the decreased stability of the EC12+13 segment of CDH23 
does indeed have a physiological role in the overall context of the tip link, this data opens my 
mind to the possibility that nature knows what it is doing.  Is it possible that this variation from 
aspartate to serine in one-out-of-twenty-seven EC repeats was created to accommodate a unique 
sequence of amino acids rather than possibly introduce a kink in the tip link like I imagined?  I 
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think it is possible even though I want to believe otherwise, but only time and results will tell its 
true purpose.  In the next section, I look to protein crystallization and X-ray crystallography for 
answers.     
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Chapter IV: Protein Crystallization and X-ray Crystallography 
 Determination of a protein’s molecular structure is a significant step towards understanding 
its function; one that is contingent on a series of experimental techniques succeeding.  The 
stepwise process of refolding the protein, obtaining crystals, collecting a diffraction data set, and 
diffraction data analysis can take anywhere from months to many years.  With nine total wild-
type and mutant CDH23 constructs generating roughly one hundred crystal trays over a two year 
period, it was only recently that I started obtaining protein crystals that were adequate in size to 
begin X-ray crystallography.  In this chapter, I will present crystals of various constructs with 
and without preliminary diffraction patterns and the methods utilized in my pursuit to someday 
achieve structural determination. 
 
4.1  Protein Crystallization via Sitting-Drop Vapor Diffusion 
  In order to make it to this point in the sequence of events, I am able to obtain at minimum 
60 µL of well-folded protein; concentrated anywhere from 2-18 mg/mL.  Growing protein 
crystals has become a high-throughput method with the commercialization of crystal screens in 
which one can test a protein against 96 different buffer conditions in a 96-well plate.  The 
Sotomayor lab has acquired more than ten of these crystallization suites from QIAGEN and 
Molecular Dimensions that contain different compositions of buffers based off of the type of salt 
present, the pH of the buffer, and the presence of possible co-factors including various 
precipitants.  A popular method, and the only technique I employed, for the crystallization of 
macromolecules is sitting drop vapor diffusion.  All crystals presented were grown and stored at 
4°C.  
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A 
B 
Figure 4.a  Setting a crystal tray for sitting drop vapor 
diffusion A) The 96-well plate B) A zoomed in view of a 
single well that effectively separates the “reservoir buffer” 
from the “drop support” so vapor diffusion can proceed 
 This method involves the 
addition of 75 µL of a unique 
buffer composition to the 
reservoir buffer, the addition of 
different ratios of protein:buffer 
in µL (0.6:0.6, 0.5:1.0, or 1.0:0.5 
depending on the concentration 
and the amount of protein you 
have available) to the drop support, and the sealing of the tray with pressure sensitive tape (Fig. 
4.a).  Please note that this process is carried out for each of the 96 wells to test for different 
buffer compositions and takes only about ten minutes per tray thanks to multi-channel and 
automated dispensing pipettes.  Vapor diffusion exploits the reagent concentration difference 
between the two separate wells of liquid as they move towards equilibrium, resulting in the 
diffusion of water from the drop support to the reservoir buffer because it contains a greater 
reagent concentration.  As water leaves the drop support containing our protein of interest, the 
sample undergoes an increase in relative supersaturation until equilibrium is reached.   
 Successful growth of a crystal does not stem from merely reaching the supersaturation 
level, but identifying the ideal parameters for inducing nucleation at the lowest degree of 
supersaturation within the “labile zone”.  The phase diagram (Fig 4.b A) illustrates just how 
important this degree of supersaturation is; at high enough levels, the protein becomes an 
unusable precipitate and if you do not reach supersaturation, the drop containing the soluble 
protein remains clear and void of crystals.  In between these two extremes, the labile zone is 
desired for nucleation because as the protein concentration gradually decreases, the system will 
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Figure 4.b  The degree of supersaturation is critical A) The solubility phase diagram for protein 
crystallization.  This diagram illustrates the stable states (liquid, crystalline, precipitate) as a function 
of two crystallization variables.  Adapted from 
53
 B) The relationship for supersaturation vs. crystal 
size, growth rate, and nucleation rates.  A high supersaturation rate results in small crystal growth 
whereas a low supersaturation rate results in faster and larger crystal growth.  Adapted from 
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A B 
be driven into the metastable zone of saturation where crystal growth is optimal.  Nucleation is 
the first step in crystallization and it refers to the three-dimensional ordering of an adequate 
amount of molecules to form a “critical nucleus”, or thermodynamically stable aggregate that can 
provide a surface suitable for further crystal growth.  From here, nucleation can proceed to 
crystal growth if diffusion results in the proper assembly of ordering molecules to the critical 
nuclei.    
 
 Unfortunately, it is not yet possible to identify the ideal conditions to support this process 
so it becomes a guess, check, and pursue strategy.  To guess, thousands of buffer conditions are 
tested via sitting drop vapor diffusion for each construct.  Periodically, the crystal trays are 
checked for any sign of growth and a plan of action is devised.  With a crystal “hit”, the 
conditions that supported growth can be pursued in a number of ways to increase the size and/or 
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diffraction capabilities of the crystal.  This is known as “refining a crystal hit” and various 
methods such as setting refinement screens, additive screens, and seeding experiments can be 
conducted.   
 
4.2  Refining Crystallization Conditions for Optimal Crystal Growth 
 Even though crystal growth is promising to see in the initial screens, these hits are typically 
used for the identification of crystallization/nucleation conditions that will allow for a more 
focused crystallization effort.  It is important to understand that the size and/or beauty of the 
crystal does not guarantee a high-resolution diffraction pattern so many crystals of various 
shapes and forms are often needed.  The examples provided were all conducted on Mm CDH23 
EC12+13
D1318N
.     
 Refinement screens around the buffer that produced the crystal are a smart first choice for 
expanding the conditions of the initial lead.  The initial buffer hit was 0.1 M MES pH 6.5 and 1.5 
M MgCl2.  The composition table (Fig. 4.c) was made in lab (versus ordering from a company) 
and sitting drop vapor diffusion with a 96-well plate was conducted in the same way as described 
above.  
              
 
 
 
 
 
 
Figure 4.c  Designing a 
refinement screen around a 
buffer composition that 
produced a crystal hit.  The 
concentration gradient of 
MgCl2, the 0.1 M MES pH, and 
the percentage of cryoprotectant 
are variables that can alter 
crystal formation for better or 
worse. 
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 The initial buffer hit [0.1 M MES pH 6.5, 1.5 M MgCl2] can also be manipulated to create 
an additive screen.  In this method, the concentrations of the initial buffer hit are not altered, but 
instead are held constant while adding one of 96-unique reagents (multivalent cations, amino 
acids, dissociating agents, linkers, polyamines, co-factors, etc.) to each well from the Additive 
Screen HT created by Hampton Research.  I added 67.5 µL of the initial buffer hit and 7.5 µL of 
a single unique reagent from the additive screen to each reservoir buffer well for a total of 75 µL.  
Next, 0.6 µL of the protein solution ranging from 2-18 mg/mL is added to the drop support and 
0.6 µL of the buffer/additive cocktail is transferred from the reservoir buffer to the drop support.  
Vapor diffusion will then occur normally with the hope of producing different crystals that will 
diffract to a higher resolution. 
 The last technique I have tried is known as random microseed matrix screening (rMMS).  
This method is based off the idea that even though a condition may support nucleation, this same 
condition may not be optimal for subsequent crystal growth and vice versa
43
.  It involves 
collecting nucleated material from one condition and transferring it to another in the attempt of 
accessing new and unexplored crystallization space.  Proponents of this technique claim that it is 
a viable method for improving crystal size, number, and quality of existing crystals or crystalline 
material.  First, the seed stock is obtained by selecting several crystallization hits of the same 
protein and thoroughly crushing the crystals in the drop support with a modified Pasteur pipette 
(Fig 4.d).  After this is accomplished, 50 µL of buffer from the reservoir solution and the crushed 
nucleation material, verified by viewing the results under a microscope, is added to a 1.5 mL 
microcentrifuge tube containing a Seed Bead designed by Hampton Research.  The suspension is 
vortexed for 2 minutes, stopping every 30 seconds to cool the tube on ice.              
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 At this point in my research, I have gone no further than one round of rMMS with each 
construct so the seed stock was not diluted
43
.  rMMS is typically utilized to test the nucleated 
protein in entirely different crystallization suites as I had done with Mm CDH23 EC12-14, but 
for Mm CDH23 EC12+13
D1318N
 I decided to reapply the nucleated protein to the refinement 
screen that generated the crystals used for seed stock.  Each reservoir buffer received 75 µL of 
buffer (remember that each well is comprised of a different buffer solution) and the drop support 
got 1 µL of protein solution, 0.5 µL of the seeding solution, and 1 µL that was transferred from 
reservoir buffer to the drop support.  Note that the protein solution is identical to the protein that 
was harvested for the seed solution, it is well-folded and will, in theory, grow off of the added 
nucleated material. 
 
 
Figure 4.d  Before and after crushing crystalline material of Mm CDH23 
EC12+13
D1318N
 for a seed stock to be used for rMMS.  The tip of a Pasteur pipette 
was heated with a Bunsen flame, pulled apart at the ends, broken, and plunged 
repeatedly into the flame to form an ~0.75 mm sphere of glass at the end.  This 
probe was used for crushing the crystals.   
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4.3  Results: Crystallization Efforts of Various Mm CDH23 Constructs 
 
Structure CDH23 EC1+2
D135S 
CDH23 EC12+13
S1316D 
CDH23 EC12+13
D1318N 
 
   
 
Conditions 
 
0.1 M CaOAc 
0.1 M MES pH 6.0 
15% PEG 400 
 
 
1.3 M MgCl2 
0.1 M MES pH 6.3 
10% glycerol 
 
1.3 M MgCl2 
0.1 M MES pH 6.5 
10% glycerol 
Space 
Group 
P6522 N/A N/A 
Resolution 3.07 Å 4.2 Å 5.29 Å 
 
 
 In December of 2015, I sent more than thirty crystals from constructs including Mm 
CDH23 EC1+2
D135S
, EC12+13
S1316D
, EC12+13
D1318N
 and EC12-14
S1316D
 to the Argonne National 
Laboratory synchrotron.  Whereas a complete diffraction data set can take one to three days to 
complete at the home source, this process is completed in a matter of seconds at this advanced 
photon source in Illinois by using high-brilliance X-ray beams.  Although I am thankful for 
finally growing crystals after setting fruitless crystal trays during my first two years with the lab, 
the resolutions for all but EC1+2 are at the upper limit.  I am still hopeful that EC12+13
S1316D
 can 
be solved to provide a rough estimate of the proteins overall shape, but EC12+13
D1318N
 will not 
be pursued at this resolution.  The EC12+13
S1316D
 and EC12+13
D1318N
 crystals shown above are 
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Figure 4.e  A mounted cryogenic loop with a 
crystal ready for X-ray crystallography to 
commence.  Notice the mother liquor stuck within 
the loop and the lack of ice formation due to 
cryoprotection.  Adopted from 
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the result of a refinement screen produced by former lab member Carissa Klanseck around the 
condition [0.1 M MES pH 6.5, 1.5 M MgCl2].  Looking at the figure above, note that these 
crystals were grown in very similar conditions with just a small shift in pH despite having two 
amino acid variations at the Ca
2+
-binding site.   
 
4.4  Diffraction Data Collection for CDH23 Constructs 
 In order to collect useful data, the protein crystals must be harvested from the crystallization 
drop in a process known as “crystal fishing” and mounted on a diffractometer to be bombarded 
with x-rays.  The task begins by isolating a droplet of protein crystals from the drop support onto 
a coverslip.  A gradient of cryoprotectant, 
a molecule that will cool to cryogenic 
temperatures without ice formation and 
damage to the crystal, ranging from low to 
high concentrations are equilibrated with 
the crystals to prepare them for the -
195.95 °C temperature of liquid nitrogen.  
Typical cryoprotectants include 
compounds like PEG, sucrose, or glycerol.  
Looking through the microscope, one uses a cryogenic loop (Hampton Research) ranging from 
0.05, 0.1, 0.2, or 0.3 mm dependent on the size of the crystal to catch and pick up the selected 
target crystal.  Once in the loop and surrounded by mother liquor, the single crystal is 
immediately flash-cooled in liquid nitrogen and stored for future data collection on an X-ray 
beamline.  Cryoprotection is very important for the freezing of the crystal and for data collection, 
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Figure 4.f  The diffraction pattern for 
EC1+2
D135S
.  This symmetrical pattern 
belongs to the P6522 space group 
as crystals can potentially crack if subjected to such an extreme temperature difference and suffer 
severe damage from high X-ray radiation if not protected. 
 Diffraction data was remotely collected on the 24 ID-E of the Advance Photon Source 
(APS) at Argonne National Laboratory.  This fixed energy beamline is optimized to address 
challenging cases in macromolecular crystallography such as poorly diffracting crystals and 
microcrystals by providing extremely stable and intense x-ray beams with beam sizes ranging 
from 5 to 70 microns.  The data was collected with the ADSC Q315 3X3 CCD/AMPTEK XR-
100SDD detectors.  Most of the crystal screening, a test to determine whether crystals are protein 
or salt, was conducted at the home source with a Rigaku MicroMax 003 and Pilatus 200k 
detector.    
 
 
4.5  From Diffraction Pattern to Atomic Model: Data Analysis of CDH23 EC1+2
D135S
 
 The crystal has now been illuminated with an 
X-ray source to provide a plethora of information, 
despite appearing as a random assortment of black 
dots arrayed on the computer screen (Fig 4.f).  The 
first task involves indexing, integrating, and then 
scaling the data set with HKL2000 (Otwinowsk and 
Minor, 1997).  Indexing involves measuring the 
intensities of the spots for one diffraction image and 
a preliminary fitting to one of fourteen Bravais 
lattices, providing information such as unit cell 
parameters and the orientation of the crystal.   
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Figure 4.g  The sequence of 
events leading to obtaining an 
atomic model for the protein of 
interest.  I am currently working 
on electron density reconstruction.  
Image adopted from 
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Once this information is optimized, integration can be performed to fit the rest of the diffraction 
images to the same parameters.  In the final step of scaling and merging, the software attempts to 
put all observations on a common scale.  With this completed, it was determined that my 
EC1+2
D135S
 crystal diffracted to 3.068 Å and was categorized by the P6522 space group. 
 All of the information needed to solve the structure 
is now available, except for the phase information.  An 
integrated suite of programs for macromolecular X-ray 
crystallography called ccp4i was utilized to elucidate 
this information.  First, the output file must be converted 
to an mtz file with the program “Scalepack2mtz”.  This 
software also analyzes the data for a common problem 
facing structural determination where inter-nuclei 
growth of two crystals is exhibited, a scenario known as 
twinning.  Fortunately, twinning was not evident in my 
data set so I continued and calculated the matthews 
coefficient with the program “Matthews_coef”.  This 
software predicts the number of molecules in the 
asymmetric unit and it was determined to be only one 
for the EC1+2
D135S
 crystal.  This is the best possible 
result, as more molecules in the asymmetric unit require more work in the refinement, which will 
be further touched upon.  Finally, the phase issue is best addressed with molecular replacement 
in this situation because it provides starting phases from a correctly positioned structurally 
similar model and, if sufficient, can be used to obtain an interpretable electron density map.  This 
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was exactly the case and “Phaser MR” was able to fit the phase information by searching with 
the individual, truncated structures of EC1 and EC2, PDB code 2WHV, that were previously 
determined by Marcos Sotomayor
33
.  Currently, I am using real- and reciprocal-space refinement 
to fit the structure generated from molecular replacement with Mm CDH23 EC1+2 to the 
experimentally obtained electron density map of CDH23 EC1+2
D135S
. 
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Data collection Mm CDH23 EC1+2 
Space group P6522 
Unit cell parameters  
a, b, c (Å) 132.14, 132.14, 136.69 
 (°) 90, 90, 120 
Molecules per asymmetric unit 1 
Beam source APS-24-ID-E 
Wavelength (Å) 0.9792 
Resolution limit (Å) 3.07 
Unique reflections 13693 
Completeness (%) 99.63 (98.78) 
Redundancy 5.8 (5.7) 
I / (I) 22.63 (2.00) 
Rmerge 0.102 (1.24) 
Rmeas 0.107 (1.30) 
Rpim 0.032 (0.39) 
CC1/2 (0.68) 
CC* (0.90) 
Refinement  
Resolution range (Å) 114.32 – 3.07 
 (3.148 – 3.068) 
Rwork (%) 22.2 (33.2) 
Rfree   (%) 25.1 (52.5) 
Residues (atoms) 208 
Ligand/ion 4 
Water molecules N/A 
Rms deviations  
Bond lengths (Å) 0.0152 
 1.8943 
B-factor average 93.009 
Ramachandran Plot Region (PROCHECK)  
Most favored (%) 80.0 
Additionally allowed (%) 17.2 
Generously allowed (%) 2.8 
Disallowed (%) 0.0 
PDB ID code Not completed 
Figure 4.h  Data collection statistics of EC1+2
D135S
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4.6  Conclusions 
 Before this semester, I was trying to figure out why crystals were not growing for my 
constructs.  Now that I solved that mystery and produced beautiful crystals that do not diffract 
well, I am met with the new challenge of making them “better”.  This does not mean a bigger or 
more geometrically shaped crystal, this means any method that will produce or alter the crystals 
so that they diffract to a sufficient resolution for structural determination.  This can be 
accomplished in two ways: growing new crystals or affecting the properties of those already in 
my crystal trays.   
 I illustrated the use of refinement screens, additive screens, and seeding methods in this 
chapter, but different techniques will also be implemented.  Cryoprotection is a crucial aspect of 
preparing protein crystals for X-ray diffraction
44
, yet I have neglected the influence these 
compounds may have on the potential diffraction.  Every crystal thus far has been protected with 
glycerol and I need to try others such as MPD, PEG 400, ethylene glycol, etc.  I have focused 
much of my time on finding the ideal buffer conditions to grow crystals and maybe the 
cryoprotectant needs to be held to this same standard.  Additionally, I will try shooting non-
frozen crystals, soaking the crystals in conditions of higher precipitant to shrink the cell, and 
annealing methods in which temperature variations from cryogenic to room temperature alters 
the crystalline properties.  With this, I am hopeful that I will overcome the setback of poor 
diffracting crystals.   
 Finally, I would like to address why the Mm CDH23 EC12+13
S1316D
 and Mm CDH23 
EC12+13
D1318N
 proteins produce very similar looking crystals whereas Mm CDH23 EC12+13 
has only been crystallized once; to give a very small, weakly diffracting crystal at that.  I do not 
have an answer, but I would like to think that the protein stability plays an important part in 
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crystallization.  Is it possible that both the engineered and diseased mutant constructs crystallize 
better than the wild-type construct because of a decreased protein stability?  It is a possibility and 
one that I hope to have an answer for within the coming months. 
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Chapter V:  Future Directions 
 The essence of hearing revolves around understanding every biochemical and physiological 
aspect of the tip link.  The Sotomayor lab is working diligently to elucidate the entire structure of 
this molecular machinery to better understand function in its entirety.  My purpose for working 
with Mm CDH23 is to explore the variation from aspartate to serine located at the SXD site 
between EC12 and 13.  Why would mother nature change a conserved Ca
2+
-binding residue in 
only one out of twenty seven instances without a purpose?  Tackling the problem from two 
different approaches, structural determination paired with biochemical methods to measure Ca
2+
-
binding affinities was utilized to obtain preliminary results detailed in their respective chapters.  
With all experimental evidence pointing at the importance of Ca
2+
, I am still hopeful that I will 
find an abnormal binding site that serves of crucial importance to the tip link yet to be 
determined, but the trypsin assays and DSF results comparing Mm CDH23 EC12+13, 
EC12+13
S1316D
, and EC12+13
D1318N
 show zero supporting evidence for this.   
 With only four months left in the lab, I am on a mission to obtain a high resolution 
diffraction pattern of Mm CDH23 EC12+13
S1316D
 and/or Mm CDH23 EC12+13
D1318N
.  There are 
more than enough crystals ready to be screened and I maintain the faith that one of them will be 
it.  The opportunity to be the first person to decipher the structure surrounding the Ca
2+
-binding 
site of interest and contribute to great research would be the highlight of my college career.    
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Additive (C4) Additive (G2) Seeding (Ref 05 – C2)  Seeding (Ref 05 – C6) 
 
 
 
 
 
0.1 M MES pH 6.5 
1.3 M MgCl2 
10% glycerol 
30% v/v Dimethyl Sulfoxide 
 
 
0.1 M MES pH 6.5 
1.3 M MgCl2 
10% glycerol 
30% w/v 1,6-Hexanediol 
 
0.1 M MES pH 6.3 
1.5 M MgCl2 
 
0.1 M MES pH 7.1 
1.5 M MgCl2 
Additive (B5) Additive (C8) Additive (H5) 
   
 
0.1 M MES pH 6.3 
1.3 M MgCl2 
10% glycerol 
1.0 M LiCl 
 
0.1 M MES pH 6.3 
1.3 M MgCl2 
10% glycerol 
30% w/v 1,6-Diaminohexane 
 
0.1M MES pH 6.3 
1.3 M MgCl2 
10% glycerol 
40% v/v Formamide 
 
 
 
Figure 5.a  Protein crystals yet to be screened A) An additive screen 
produced the following crystals for Mm CDH23 EC12+13
S1316D
.  The crystal 
grown in B5 is indicative of many more crystals not pictured, but the C8 and 
H5 crystals have a unique cube shape that is not seen in other buffer 
conditions B) An additive screen and random microseed matrix screening 
produced the following crystals for Mm CDH23 EC12+13
D1318N
 plus many 
more not pictured.  The C4 and G2 crystals are very similar in shape to 
crystals that have been determined to not diffract well.  However, this has no 
bearing on how well they will diffract, it must be determined experimentally.  
The C2 and C6 crystals from a previous refinement screen I created are the 
first crystals I have grown from seeding so I am excited to screen them as 
they look different in shape from the typical crystals I grow. 
A 
B 
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Biochemistry Undergrad Spotlight Questionnaire: 
Thank you for participating in the Biochemistry Undergrad Spotlight! We will be featuring a 
new Undergraduate student each month in order to highlight their academic accomplishments 
and connect with other current and future Biochemistry students. Please fill out the questionnaire 
to the best of your ability and do not hesitate to ask if you have questions or comments.  
 
1. What is your academic standing, major, and favorite class taken so far at OSU? 
 
I am a 4
th
 year biochemistry/pre-med student and my favorite class has been 
Biochemistry 5614, if not the entire biochemistry series. To put the science foundation 
gained from the biology and general/organic chemistry courses into the context of life 
was fascinating, especially the highly complex and integrative metabolic processes of our 
bodies.      
 
2. What is your favorite aspect of working in the Biochemistry Labs? 
 
It is an awesome experience to join a lab with limited knowledge, get trained to 
understand the theory and methodology behind your work, and then become more and 
more independent over time as you develop your own research project. I never thought 
that as an undergraduate student, I would have an opportunity to contribute new 
knowledge that could shape the scientific community.  
 
With two years in The Sotomayor Research Group, I have had a wonderful experience in 
undergraduate research because of the people that surround me. Working with those that 
have different interests, levels of educational attainment, and backgrounds to solve a 
common goal not only motivates, but makes you realize what it takes to be successful. 
The mentorship that comes with research is indispensable. 
 
 
3. What is the main focus of the research in your lab and what impact do you think it will 
make? 
 
As a member of The Sotomayor Research Group, I am studying a portion of a protein 
complex known as the tip link, a core component of vertebrate hearing. From protein 
biochemistry to X-ray crystallography, I get to utilize a wide range of techniques with the 
goal of elucidating the molecular mechanisms underlying normal hearing and deafness. 
Ultimately, by understanding the mechanisms at play, our lab will be able to manipulate 
the system and contribute to curing some forms of deafness, whether genetic or noise-
induced.   
 
Check us out: https://research.cbc.osu.edu/sotomayor.8/ 
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4. How would you encourage prospective students to engage with the Biochemistry 
Department? 
 
If you are a biochemistry student, I would strongly recommend enrolling in Biochemistry 
2900H, a course offered in the Autumn semester that allows you to listen to various 
professors in the department and join a lab based off of your interests (if a spot is 
available). Equally effective, do not hesitate to contact a professor expressing your 
interest in their lab; the worst they can say is “no thank you”. Most importantly, 
professors are people to that are generally very friendly, easy to talk to, and excited that 
you have taken interest in their work. Also, research forums are a great way to interact 
with your peers and identify subjects that may be of interest to you.   
 
 
5. What advice would you give to future students studying Biochemistry? 
 Do NOT let your current knowledge or academic standing hold you back from partaking 
 in research. From personal experience, I arrived at Ohio State without a strong foundation 
 in science; illustrated by the fact that proteins were foreign to me until my  first biology 
 course. Honestly, I was intimidated by not only the complexity of research topics, but by 
 the thought of working with other undergrads, graduate students, and post-docs that are 
 brilliant. Yet, I caught on and you will as well; it is amazing how fast you learn when you 
 can interact with science outside of a textbook.    
 Based off of my experience in and around the research community at The Ohio State 
 University, I would advise any future biochemistry student to make it a priority to partake 
 in research; whether you want to get a PhD, go to professional school, or join the 
 workforce right out of college. And do not feel constrained to biochemistry research, 
 explore the many options available and pick a group that suits your interests whether the 
 subject is interpretative dance, the impact of music in developing nations, or studying 
 extended care for piglets. The options are endless and the impact on your education 
 tremendous. Best of luck! 
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